Search results

This study aims to examine the impact of disclosure on the unsolved initial public offering (IPO) puzzle. For this purpose, the authors analyzed the impact of the primary uses of the proceeds disclosed in a firm's IPO prospectus on underpricing, prelisting performance, postlisting underperformance and operating performance.

This study uses Indian public firms that went public between March 31, 2010, and March 31, 2020. A multivariate regression technique was used to study the impact of the primary uses of proceeds on underpricing, prelisting performance and postlisting underperformance, whereas a quantile regression technique was used to study their impact on operating performance.

The authors found that the primary use of proceeds disclosure helps predict underpricing and returns to the investor only until day 60 postlisting; beyond that, they provide no further insights into the firm's performance. Firms with lower and average operating performance should not state the general corporate purposes and payment on borrowings, respectively, as their primary use of proceeds, as it leads to a decline in their operating performance.

Results might suffer from the potential endogeneity problem due to selection bias. This research focuses on India only, which makes generalization of results for other economies difficult. Future research may extend the post-IPO period and include more developing economies. Furthermore, future studies can draw comparisons between developed and developing nations' disclosures of using proceeds.

This study will help the firms going public in India better disclose the use of proceeds based on their characteristics. Stating future acquisitions, payments on borrowings and working capital reduces the uncertainty, and therefore, these are feasible avenues for investing proceeds raised through IPO.

The authors used ten categories for the primary use of proceeds disclosure, whereas previous studies have used only five to six categories. To the best of the authors’ knowledge, this study was the first to use underpricing, postlisting performance and operating performance in a single study. These measures gave a more holistic view of the use of proceeds disclosure.